Eisai Aktie
| 26,18EUR | -0,01EUR | -0,04% |
WKN: 855526 / ISIN: JP3160400002
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 85,78 |
| Vanguard Health Care Fund | 6,45 |
| Government of Japan | 3,76 |
| Eisai Co., Ltd. | 3,21 |
| Nomura Asset NEXT FUNDS NIKKEI 225 ETF (1321) | 2,98 |
| Nikko Asset Management Co., Ltd. | 2,84 |
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | 2,67 |
| Nomura Asset NEXT FUNDS TOPIX ETF (1306) | 2,62 |
| Nippon Life Insurance Co. | 2,19 |
| American Funds EuroPacific Growth Fund | 2,14 |
| Nikko Exchange Traded Index Fund 225 | 1,44 |
| The Naito Foundation | 1,42 |
| Resona Holdings, Inc. | 1,28 |
| Tokio Marine Holdings, Inc. | 0,58 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 10 998 | 11 237 | 11 322 | 11 076 | 11 067 |
| Umsatz pro Mitarbeiter in Mio. EUR | 63,25 | 57,48 | 66,79 | 67,21 | 67,02 |
Bilanz (in Mio. JPY) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 520 837 | 517 886 | 640 260 | 621 847 | 722 237 |
| Summe Anlagevermögen | 541 303 | 572 123 | 599 055 | 641 503 | 671 562 |
| Summe Aktiva | 1 062 140 | 1 090 009 | 1 239 315 | 1 263 350 | 1 393 799 |
Bilanz (in Mio. JPY) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 359 509 | 362 067 | 467 781 | 440 779 | 494 825 |
| Summe Eigenkapital | 702 630 | 727 942 | 771 533 | 822 571 | 898 975 |
| Summe Passiva | 1 062 139 | 1 090 009 | 1 239 314 | 1 263 350 | 1 393 800 |
Adresse
| 4-6-10 Koishikawa, 112-8088 Tokyo | |
| Telefon | +81 (3) 3817-3030 |
| Internet | http://www.eisai.co.jp |
Management
|
Akiko Nakahama
Chief Portfolio Officer & Regulatory Affairs |
|
Clive Richard Thornley
Independent Outside Director |
|
Fumihiko Ike
Independent Outside Director |
|
Gary Bryan Hendler
Managing Executive Officer & President-EMEA |
|
Haruo Naito
Chief Executive Officer & Director |
|
Hiroyuki Kato
Director |
|
Kanai Sawaji
Independent Outside Director |
|
Keisuke Naito
Executive VP, Chief Operating & Growth Officer |
|
Kenta Takahashi
Director |
|
Lynn D. Kramer
Chief Clinical Officer & Vice President |
|
Makoto Hoketsu
Chief Information Officer |
|
Masatomi Akana
SVP, Chief Government & Investor Relations Officer |
|
Mitsuru Shomon
Chief Financial Officer & Head-Accounting |
|
Ryota Miura
Independent Outside Director |
|
Sayoko Sasaki
Vice President-Communications & Sustainability |
|
Shin Kato
Chief Compliance Officer, VP & General Counsel |
|
Shin Ujiie
Director-Strategy Officer |
|
Shinichi Sagawa
Head-Finance & Accounting |
|
Shohei Kanazawa
President-Asia & Latin America Region |
|
Takashi Owa
Chief Scientific Officer & Senior Vice President |
|
Terushige Iike
Executive VP, Chief Strategy & Planning Officer |
|
Teruyuki Masaka
Executive Officer & Chief Human Resources Officer |
|
Toru Moriyama
Independent Outside Director |
|
Toshitaka Asano
Executive Officer & Head-Business Development |
|
Yan Hui Feng
Senior Vice President |
|
Yasushi Okada
Head-Industry Affairs & Internal Audit |
|
Yoshiteru Kato
Director |
|
Yuko Yasuda
Independent Outside Director |
|
Yumiko Miwa
Independent Outside Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
